Back
Expedia Group Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
96
EXPE
Expedia Group
Last Price:
180.76
Seasonality Move:
7.02%
Buy
100
RYTM
Rhythm Pharmaceuticals
Last Price:
67.31
Seasonality Move:
9.98%
Buy
96
Expedia Group (EXPE)
is a Buy
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $180.76. The Score for EXPE is 96, which is 92% above its historic median score of 50, and infers lower risk than normal.
- EXPE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
100
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $180.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $67.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.55 | Buy |
| Relative Strength Index (14 RSI): | 79.25 | Buy |
| Chaikin Money Flow: | -3727208 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (150.95 - 166.47) | Buy |
| Bollinger Bands (100): | (124.96 - 153.06) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 81.29 | Buy |
| Chaikin Money Flow: | 966983 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.36 - 56.78) | Buy |
| Bollinger Bands (100): | (43.87 - 52.87) | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 166.2 | Buy |
| 20-day SMA: | 160.53 | Buy |
| 50-day SMA: | 149.47 | Buy |
| 200-day SMA: | 134.76 | Buy |
| 8-day EMA: | 168.82 | Buy |
| 20-day EMA: | 161.76 | Buy |
| 50-day EMA: | 151.91 | Buy |
| 200-day EMA: | 136.2 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.18 | Buy |
| 20-day SMA: | 52.43 | Buy |
| 50-day SMA: | 50.91 | Buy |
| 200-day SMA: | 45.07 | Buy |
| 8-day EMA: | 58.59 | Buy |
| 20-day EMA: | 54.14 | Buy |
| 50-day EMA: | 51.2 | Buy |
| 200-day EMA: | 44.61 | Buy |
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.25 per share, and an increase next year of $2.27 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Expedia Group Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||